Tests a structured wellness program for quality of life in NMOSD
Tests a multi-part wellness program in adults living with NMOSD.
Plain-language title generated from the registry record
Registry title: Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- Corinne Goldsmith Dickinson Center for MS at Mount SinaiNew York, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Trial code
- NCT06780709
- Record updated
- 2 November 2026
- Original description
This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical therapists, dietitians, social workers, nurse practitioners and cognitive therapists. The trial will be designed as a randomized controlled trial, randomizing patients to immediately starting the program as well as a 6 month delayed start. The intervention would leverage an existing clinical comprehensive MS wellness program at the Corinne Dickinson for Multiple Sclerosis (MS) at Mount Sinai Medical Center. The primary endpoint of this study would be evaluating quality of life, as assessed by MS-Quality of Life -54.Read full original descriptionShow less
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical therapists, dietitians, social workers, nurse practitioners and cognitive therapists. The trial will be designed as a randomized controlled trial, randomizing patients to immediately starting the program as well as a 6 month delayed start. The intervention would leverage an existing clinical comprehensive MS wellness program at the Corinne Dickinson for Multiple Sclerosis (MS) at Mount Sinai Medical Center. The primary endpoint of this study would be evaluating quality of life, as assessed by MS-Quality of Life -54.
Inclusion: Adults (age ≥18) with NMOSD diagnosed with 2015 NMOSD clinical criteria; All EDSS scores will be considered in order to make the intervention accessible to all patients regardless of disability; All patients regardless of treatment type will be considered.
Exclusion: Inability to participate in study evaluation and/or endpoint measures, or participation in another concurrent randomized controlled trial or wellness based intervention; Age<18; Inability to voluntarily provide consent for study participation; Any patients with a relapse within 30 days of randomization or any patients with medical restrictions on physical activity will be excluded; Any patients who begin stimulants and/or dalfampridine between enrollment and randomization will be excluded.